The recent development and Food and Drug Administration approval in 2016 of dorsal root ganglion stimulation is a relatively new and novel form of target neuromodulation that promises improved outcomes compared with the current standard of care. Current literature is limited and dependent on industry evaluation. Future independent investigation will help clarify existing data and refine techniques to improve safety, effectiveness, and expand application.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pmr.2022.02.005 | DOI Listing |
Publication Analysis
Top Keywords
dorsal root
8
root ganglion
8
ganglion stimulation
8
stimulation development
4
development food
4
food drug
4
drug administration
4
administration approval
4
approval 2016
4
2016 dorsal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!